Report #2843489

Received Jun 2, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex: Male
Age: 58 yrs
State: MN
Recovered: Unknown
Vaccinated: May 7, 2018
Onset: May 7, 2018
Days to onset: 0
Hospital days: —

Vaccines (1)

Type	Name	Manufacturer	Dose	Lot	Route / Site
VARZOS	ZOSTER (SHINGRIX)	GLAXOSMITHKLINE BIOLOGICALS	1	LT533	—

Symptoms (2)

FatiguePain in extremity

Symptom narrative

accentuated fatigue; pain in injection arm; This non-serious case was reported by a physician via call center representative and described the occurrence of fatigue aggravated in a 58-year-old male patient who received Herpes zoster (Shingrix) (batch number LT533) for prophylaxis. On 07-MAY-2018, the patient received the 1st dose of Shingrix. On 07-MAY-2018, less than a day after receiving Shingrix, the patient experienced fatigue aggravated (Verbatim: accentuated fatigue) and pain in arm (Verbatim: pain in injection arm). The outcome of the fatigue aggravated and pain in arm were unknown. It was unknown if the reporter considered the fatigue aggravated and pain in arm to be related to Shingrix. It was unknown if the company considered the fatigue aggravated and pain in arm to be related to Shingrix. Additional Information: GSK receipt date: 22-MAY-2025 The patient experienced pain in arm, with an accentuated fatigue after the first dose of Shingrix.; Sender's Comments: US-GSK-US2025068287:For 2nd dose shingrix